Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.776 | 0.240 | 2 | 25234373 | missense variant | C/A;G;T | snv | 4.0E-06; 4.0E-06; 2.2E-04 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2014 | 2019 | |||||||
|
0.776 | 0.240 | 2 | 25234373 | missense variant | C/A;G;T | snv | 4.0E-06; 4.0E-06; 2.2E-04 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.240 | 2 | 25234374 | missense variant | G/A;C;T | snv | 1.2E-04; 8.0E-06 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.120 | 2 | 25239208 | missense variant | G/A;C;T | snv | 4.0E-06; 1.2E-05; 4.0E-06 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.790 | 0.320 | 2 | 25343038 | upstream gene variant | A/G;T | snv |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.882 | 0.080 | 2 | 25262866 | intron variant | C/T | snv | 0.45 |
|
Nervous System Diseases; Mental Disorders | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.120 | 2 | 25278036 | intron variant | C/A | snv | 6.6E-03 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 2 | 25240614 | intron variant | G/A | snv | 0.41 | 0.41 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.882 | 0.200 | 2 | 25247710 | stop gained | T/A;G | snv | 4.0E-06 |
|
Behavior and Behavior Mechanisms | 0.700 | 0 | ||||||||||
|
2 | 25260101 | intron variant | A/G | snv | 0.22 |
|
0.700 | 1.000 | 2 | 2015 | 2019 | ||||||||||
|
2 | 25250442 | intron variant | G/A | snv | 0.43 |
|
0.700 | 1.000 | 2 | 2017 | 2019 | ||||||||||
|
1.000 | 0.040 | 2 | 25240614 | intron variant | G/A | snv | 0.41 | 0.41 |
|
0.700 | 1.000 | 1 | 2014 | 2014 | |||||||
|
2 | 25235984 | intron variant | A/G | snv | 4.8E-02 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
2 | 25289569 | intron variant | T/G | snv | 0.48 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.827 | 0.120 | 2 | 25269598 | intron variant | A/G | snv | 0.31 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | < 0.001 | 1 | 2019 | 2019 | |||||||
|
0.790 | 0.320 | 2 | 25343038 | upstream gene variant | A/G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.827 | 0.120 | 2 | 25278036 | intron variant | C/A | snv | 6.6E-03 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.790 | 0.320 | 2 | 25343038 | upstream gene variant | A/G;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.120 | 2 | 25312674 | intron variant | T/C | snv | 0.42 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.120 | 2 | 25269598 | intron variant | A/G | snv | 0.31 |
|
Digestive System Diseases | 0.800 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.827 | 0.120 | 2 | 25278036 | intron variant | C/A | snv | 6.6E-03 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.200 | 2 | 25247710 | stop gained | T/A;G | snv | 4.0E-06 |
|
Behavior and Behavior Mechanisms | 0.700 | 0 | ||||||||||
|
1.000 | 0.120 | 2 | 25246231 | missense variant | G/A | snv | 8.0E-06 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.776 | 0.240 | 2 | 25234373 | missense variant | C/A;G;T | snv | 4.0E-06; 4.0E-06; 2.2E-04 |
|
0.700 | 1.000 | 36 | 1989 | 2018 | ||||||||
|
1.000 | 0.040 | 2 | 25291464 | intron variant | C/T | snv | 0.40 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 |